Education：

• Ph.D. in Pharmaceutical Chemistry China Medical University

Areas of Expertise：

• De Novo Drug Design
• Innovative Drug Delivery System Development
• Planning and Strategy for New Drug Development and Project Selection

Professional Summary :
    Dr. Hsieh holds a Ph.D. in Pharmaceutical Chemistry from China Medical University. He previously worked as a practicing pharmacist at ophthalmology clinics and Chang Gung Memorial Hospital, gaining extensive clinical experience.
    Dr. Hsieh served as the principal investigator or co-principal investigator in a total of 47 research projects under the TFDA, including the Bioavailability and Bioequivalence Research Program and the Rare Diseases Drugs Annual Report Research Program. He has amassed extensive experience in drug development and quality control.
    From Dr. Hsieh transitioned into the biotechnical industry, he leveraged his experience to lead the license-in projects from NHRI, DCB, and ITRI, both in the past and present, significantly enhancing the company's R&D efficiency and corporate value.